Open Arsenal

Every Recall. Every Company. Clearly.

MediLens is an open-source, real-time global database designed to bring transparency and accountability to the pharmaceutical industry. It tracks official recalls for prescription drugs, biologics, and vaccines worldwide, compiling them into a centralized, publicly accessible platform. By combining detailed medication profiles with comprehensive recall histories, MediLens allows users to clearly see how safe a product or company has been over time.

One of its core strengths is the creation of pharmaceutical company profiles and medication safety scoring. Each company is evaluated based on a safety ratio that compares the number of approved products to the number of recalls, giving users a clear, data-driven view of reliability. Medications are also tracked individually, with full recall details including dates, reasons, severity levels, and affected regions. This structured approach transforms fragmented regulatory data into meaningful, comparable insights.

MediLens also emphasizes real-time awareness and accessibility. It integrates with official regulatory sources to provide up-to-date recall information, which is then surfaced through public dashboards, alert systems, and RSS feeds. Users can search by medication, company, country, or recall severity, and subscribe to alerts tailored to their interests. Interactive charts and downloadable reports make it useful not only for the public, but also for researchers, journalists, and healthcare professionals.

Beyond tracking, MediLens includes advanced analytics and optional predictive features. These range from recall trend analysis and severity heatmaps to anomaly detection and risk forecasting based on historical data. Combined with open APIs, export tools, and community-driven enhancements, MediLens evolves into more than just a database—it becomes a global pharmaceutical intelligence platform focused on clarity, safety, and informed decision-making.